ReviewCureus2025
Assessing the Health Impacts of Heated Tobacco Products Compared to Traditional Tobacco Use: A Systematic Review of Current Evidence.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Moderating Effect of Physical Activity Between IQOS Smoking and Ventricular Repolarization Parameters in Lebanese University Students.Health science reports · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heated tobacco products (HTPs) have emerged as alternatives to conventional cigarettes, promoted for their potential harm reduction by heating instead of burning tobacco. While HTPs are increasingly used worldwide, their comparative health impact relative to traditional smoking remains unclear. This systematic review and meta-analysis aimed to assess and compare the health effects of HTPs and conventional combustible tobacco products, focusing on clinical outcomes, biomarkers of exposure and harm, respiratory and oral health, and usage patterns. A comprehensive literature search was conducted across PubMed, Cochrane Library, Scopus, ScienceDirect, and DelNet, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. Eligible studies included adult human participants comparing HTPs and conventional cigarette use, reporting at least one health-related outcome. Data extraction and quality assessment were performed independently by two reviewers. Risk of bias was evaluated using the RoB 2.0 tool for randomized controlled trials and the Risk of Bias in Non-randomized studies of Interventions tool for non-randomized studies. A random-effects meta-analysis was performed wherever appropriate. In total, 20 studies met the inclusion criteria. A meta-analysis of nine outcome measures revealed consistently lower levels of harm among HTP users compared to smokers. Improvements were observed in pulmonary function (mean forced expiratory volume in one second differences: 0.13-0.21 L), and significantly reduced levels of biomarkers including 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (-0.42 ng/mL), interleukin-6 (-24.6 pg/mL), tumor necrosis factor-alpha (-15.2 pg/mL), C-reactive protein (-1.3 mg/L), 8-hydroxy-2'-deoxyguanosine (-1.6 ng/mL), and lactate dehydrogenase (-30 U/L), all with p-values <0.001. Cotinine levels and nicotine dependence scores were also significantly lower in HTP users. Additionally, oral health outcomes such as tooth discoloration and Simplified Oral Hygiene Index scores favored HTP users. Behavioral indicators suggested fewer tobacco use days per month and lower dependence among HTP users. No included study reported worse health outcomes in HTP users relative to smokers. While not risk-free, HTPs appear to be associated with significantly lower exposure to toxicants, reduced inflammation, and improved health indicators compared to traditional smoking. Due to study heterogeneity and limited long-term data, the meta-analytic findings should be interpreted with caution. Further independent, long-term research is needed to fully establish the risk profile of HTPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.